Rapid Risk Assessment: Louse-borne relapsing fever in the EU, 19 November 2015
This rapid risk assessment assesses the public health significance of reported cases of louse-borne relapsing fever in the EU.
Communicable disease threats report, Week 31, 26 July - 1 August 2015
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 26 July - 1 August 2015, and includes updates on anthrax, cutaneous diphtheria, louse-born relapsing fever, West Nile fever, measles, rubella and Ebola virus.
- Ebola haemorrhagic fever
- Emerging and Vector-borne Diseases Programme
- louse-borne disease
- Middle East respiratory syndrome coronavirus
- public health threat
- Vaccine Preventable Diseases Programme
- West Nile fever
Rapid risk assessment: Louse-borne relapsing fever in the Netherlands, 27 July 2015
Following reports from the Netherlands of two cases of louse-borne relapsing fever in asylum seekers coming from Eritrea, ECDC has assessed the risk to Europe.
Facts about Bartonella quintana infection (‘trench fever’)
Bartonella quintana infection (historically called ‘trench fever’) is a vector-borne disease primarily transmitted by the human body louse. It has been recognised as a reemerging pathogen among impoverished and homeless populations — so-called ‘urban trench fever’.
Facts about louse-borne relapsing fever
Louse-borne relapsing fever (LBRF) is a vector-borne disease transmitted by the body louse Pediculus humanus humanus. The disease can be severe. Currently the disease is primarily found in north-eastern Africa.
Threats and outbreaks of louse-borne relapsing fever
Cases of louse-borne relapsing fever were diagnosed in EU and Switzerland in the end of 2015. These cases, diagnosed among refugees from countries of the Horn of Africa are not unexpected as the disease is present in north-eastern Africa.